Asiatic Laboratories Limited (DSE: ASIATICLAB)
Health Care · Pharmaceuticals · BD
Tk107.30
+2.88% today · +117.2% 1Y
Public summary
A free snapshot of Asiatic Laboratories Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Asiatic Laboratories Limited (DSE: ASIATICLAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $104.89M.
Over the last twelve months the share price has gained 117.2%, trading between 44.20 and 146.90.
Tweenvest scores Asiatic Laboratories Limited across four factors: quality 68/100, value 60/100, growth 1/100, dividend 37/100. Its strongest factor is quality.
ASIATICLAB price history
Key figures
- Market cap
- $104.89M
- Revenue (TTM)
- $23.69M
- P/E
- 24.72
- EPS
- 2.09
- Dividend yield
- 0.93%
- Beta (5Y)
- 0.52
- 52-week high
- Tk146.90
- 52-week low
- Tk44.20
- Avg volume (3M)
- —
- Shares outstanding
- 122.39M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CellBion Co., Ltd.KOSDAQ: A308430 | $108.06M | ₩11,180.00 | -1.41% |
| Vikram Thermo (India) LimitedBSE: 530477 | $106.36M | Rs319.80 | -0.11% |
| RaQualia Pharma Inc.TSE: 4579 | $105.18M | ¥646.00 | -3.15% |
| BGM Group Ltd.NasdaqCM: BGM | $105.16M | $7.88 | +2.27% |
| Journey Medical CorporationNasdaqCM: DERM | $104.15M | $3.69 | -5.38% |
| Organigram Global Inc.TSX: OGI | $102.49M | CA$1.04 | -11.86% |
| Semnur Pharmaceuticals, Inc.OTCPK: SMNR | $102.32M | $0.47 | +42.42% |
| Retension Pharmaceuticals, Inc.NasdaqCM: RTSN | $102.23M | $12.27 | +0.16% |